Literature DB >> 9180621

Prognostic significance of the white coat effect.

P Verdecchia1, G Schillaci, C Borgioni, A Ciucci, C Porcellati.   

Abstract

The difference between clinic and ambulatory blood pressure (BP) has been used to quantify the pressure reactivity to the doctor's visit (white coat effect). We investigated the prognostic significance of the clinic-ambulatory BP difference in the setting of the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale (PIUMA) study. A total of 1522 subjects contributed 6371 person-years of observation. All subjects had an initial off-therapy diagnostic workup including 24-hour noninvasive ambulatory BP monitoring. The predicted values of ambulatory BP progressively diverged from the identity line (white coat effect of 0 mm Hg) with increasing clinic BP, but the predicted values of clinic BP tended toward the identity line with increasing ambulatory BP. Hence, the clinic-ambulatory BP difference showed a direct association with clinic BP and an inverse association with ambulatory BP. Consequently, a high clinic-ambulatory BP difference predicted both a high clinic and a low ambulatory BP, whereas a low clinic-ambulatory BP difference predicted both a low clinic and a high ambulatory BP. The clinic-ambulatory BP difference showed also a direct association with age. During up to 9 years of follow-up (mean, 4.2 years), there were 157 major cardiovascular morbid events (125 nonfatal and 32 fatal). The rate of total cardiovascular morbid events did not differ (log-rank test) among the four quartiles of the distribution of the clinic-ambulatory BP difference (2.13, 2.92, 2.10, and 2.83 events per 100 patient-years for systolic BP and 2.94, 2.14, 2.58, and 2.16 events per 100 patient-years for diastolic BP). Also, the rate of fatal cardiovascular events did not differ among the four quartiles of the distribution of the clinic-ambulatory BP difference. The clinic-ambulatory BP difference, taken as a measure of the white coat effect, does not predict cardiovascular morbidity and mortality in subjects with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180621     DOI: 10.1161/01.hyp.29.6.1218

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

1.  Measurement and interpretation of blood pressure.

Authors:  C D Goonasekera; M J Dillon
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

Review 2.  Importance of various methods of blood pressure measurement in clinical trials.

Authors:  P Palatini
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

3.  A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Authors:  Linnea A Polgreen; Barry L Carter; Philip M Polgreen; Peter M Snyder; Daniel K Sewell; Emine O Bayman; Shelby L Francis; Jacob E Simmering; Christopher Parker; Rachel Finkelstein
Journal:  Contemp Clin Trials       Date:  2020-10-07       Impact factor: 2.226

Review 4.  Modern approaches to blood pressure measurement.

Authors:  J A Staessen; E T O'Brien; L Thijs; R H Fagard
Journal:  Occup Environ Med       Date:  2000-08       Impact factor: 4.402

5.  Prevalence and predictors of white-coat response in patients with treated hypertension.

Authors:  M B MacDonald; G P Laing; M P Wilson; T W Wilson
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

6.  White coat effect and white coat hypertension: one and the same?

Authors:  As Ramli; N Halmey; Cl Teng
Journal:  Malays Fam Physician       Date:  2008-12-31

7.  Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study.

Authors:  Farnaz Memarzadeh; Mei Ying-Lai; Jessica Chung; Stanley P Azen; Rohit Varma
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

8.  Predictors for the white coat effect in general practice patients with suspected and treated hypertension.

Authors:  Morten Lindbaek; Endre Sandvik; Kåre Liodden; Johnny Mjell; Kai Ravnsborg-Gjertsen
Journal:  Br J Gen Pract       Date:  2003-10       Impact factor: 5.386

Review 9.  Clinical benefits of consistent reduction in the daily blood pressure of hypertensive patients.

Authors:  Giuseppe Mancia
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jul-Aug       Impact factor: 3.738

10.  What is the true blood pressure? Smirk revisited.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.